Charting Venetoclax Sensitivity and Synergism Ex Vivo in Multiple Myeloma

被引：0
|
作者：
Meurice, Nathalie
Petit, Joachim L.
Todsen, Jessica L.
De Campos, Cecilia Bonolo
Polito, Alysia N.
Armenta, Ilsel D. Lopez
Ahmann, Gregory J.
Stewart, A. Keith
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3081
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ex vivo sensitivity to venetoclax is predictive of clinical activity
    de Campos, Cecilia Bonolo
    Meurice, Nathalie
    Bruins, Laura A.
    Petit, Joachim L.
    Polito, Alysia N.
    Wang, Xuewei
    Zhu, Yuan Xiao
    Shi, Chang-Xin
    Ahmann, Greg J.
    Braggio, Esteban
    Stewart, Keith
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E114 - E114
  • [2] Alvocidib Enhances Venetoclax Sensitivity in Unfavorable-Risk Multiple Myeloma Cells In Vitro and In Vivo
    Zhou, Liang
    Zhang, Yu
    Sampath, Deepak
    Leverson, Joel D.
    Dai, Yun
    Kmieciak, Maciej
    Nguyen, Matthew
    Orlowski, Robert Z.
    Grant, Steven
    [J]. BLOOD, 2017, 130
  • [3] Ex vivo modeling of multiple myeloma: A novel drug sensitivity screening platform
    Sambandam, Vaishnavi
    Inamdar, Sharvari
    Hsu, Haoting
    Walling, Brandon
    Schiviani, Paolo
    Andar, Abhay
    Zipeto, Marianna
    Ritchie, Michael
    Heidemann, Karin Abarca
    Mancini, Maria
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [4] Biomarker and Ex Vivo Sensitivity Analysis of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma
    Ross, Jeremy
    Amiot, Martine
    Chyla, Brenda
    Roberts-Rapp, Lisa
    Goswami, Rasna
    Yan, Sun
    Huang, Xin
    Bhathena, Anahita
    Enschede, Sari Heitner
    Maciag, Paulo
    Humerickhouse, Rod A.
    McKeegan, Evelyn
    [J]. BLOOD, 2015, 126 (23)
  • [5] Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically
    Giliberto, Mariaserena
    Thimiri Govinda Raj, Deepak B.
    Cremaschi, Andrea
    Skanland, Sigrid S.
    Gade, Alexandra
    Tjonnfjord, Geir E.
    Schjesvold, Fredrik
    Munthe, Ludvig A.
    Tasken, Kjetil
    [J]. MOLECULAR ONCOLOGY, 2022, 16 (06) : 1241 - 1258
  • [6] Predicting Venetoclax Sensitivity in Multiple Myeloma Using Biologic Activity Assays
    Matulis, Shannon
    Gupta, Vikas A.
    Tang, Zenchu
    Shah, Shardule
    Adewuya, Tolu
    Nooka, Ajay
    Kaufman, Jonathan L.
    Lonial, Sagar
    Boise, Lawrence H.
    [J]. BLOOD, 2017, 130
  • [7] Succinate Ubiquinone Reductase Activity Predicts Multiple Myeloma Sensitivity to Venetoclax
    Bajpai, Richa
    Wei, Changyong
    Matulis, Shannon
    Nooka, Ajay K.
    McBrayer, Samuel
    Lonial, Sagar
    Gupta, Vikas A.
    Boise, Lawrence H.
    Shanmugam, Mala
    [J]. BLOOD, 2017, 130
  • [8] Venetoclax for the treatment of multiple myeloma
    Vaxman, Iuliana
    Sidiqi, M. Hasib
    Gertz, Morie
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (12) : 915 - 920
  • [9] Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
    Richa Bajpai
    Aditi Sharma
    Abhinav Achreja
    Claudia L. Edgar
    Changyong Wei
    Arusha A. Siddiqa
    Vikas A. Gupta
    Shannon M. Matulis
    Samuel K. McBrayer
    Anjali Mittal
    Manali Rupji
    Benjamin G. Barwick
    Sagar Lonial
    Ajay K. Nooka
    Lawrence H. Boise
    Deepak Nagrath
    Mala Shanmugam
    [J]. Nature Communications, 11
  • [10] Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma
    Shannon M. Matulis
    Vikas A. Gupta
    Paola Neri
    Nizar J. Bahlis
    Paulo Maciag
    Joel D. Leverson
    Leonard T. Heffner
    Sagar Lonial
    Ajay K. Nooka
    Jonathan L. Kaufman
    Lawrence H. Boise
    [J]. Leukemia, 2019, 33 : 1291 - 1296
12345